Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12417753rdf:typepubmed:Citationlld:pubmed
pubmed-article:12417753lifeskim:mentionsumls-concept:C0005974lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C1325331lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C0533294lld:lifeskim
pubmed-article:12417753lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:12417753pubmed:dateCreated2002-11-13lld:pubmed
pubmed-article:12417753pubmed:abstractTextIL-6 is a multifunctional cytokine involved in regulation of differentiation, antibody production, and growth of certain types of tumor cells. Its excessive production plays a major role in pathogenesis of multiple myeloma and postmenopausal osteoporosis. In the course of a screening program aimed at IL-6 inhibitor from microbial products, we found madindoline A (MDL-A) and madindoline B, which have a fuloindoline structure with diketocyclopentene bound to the methyl group. MDL-A has no cytotoxic activities. It inhibited only activities of both IL-6 and IL-11 without affecting the IL-6-specific signal transduction cascade, JAK2/STAT3. In a dose-dependent manner [(3)H]MDL-A binds to gp130, which is a signal transducing 130-kDa glycoprotein, but formation of the trimeric complex IL-6/IL-6 receptor/gp130 was not inhibited, suggesting that MDL-A suppresses dimerization of trimeric complexes. Not only did MDL-A markedly inhibit IL-6- and IL-11-induced osteoclastogenesis in vitro, but it also inhibited IL-6-stimulated serum amyloid A production and bone resorption in an experimental model of postmenopausal osteoporosis in vivo by a different mechanism from that of 17beta-estradiol. Here we show that MDL-A has a highly selective inhibitory effect on IL-6 and IL-11 activities by inhibiting a gp130 activity while suppressing bone loss in ovariectomized mice. MDL-A is anticipated as a lead compound for treatment of hormone-dependent postmenopausal osteoporosis, which has no serious side effects, and as a new mechanism of action, gp130 blocking.lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:languageenglld:pubmed
pubmed-article:12417753pubmed:citationSubsetIMlld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12417753pubmed:statusMEDLINElld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:SunazukaToshi...lld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:OmuraSatoshiSlld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:HiroseTomoyas...lld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:KikuchiYujiYlld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:FukamiAkikoAlld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:HayashiMasahi...lld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:KomiyamaKanki...lld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:RhoMun-ChualM...lld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:EnomotoAkikoAlld:pubmed
pubmed-article:12417753pubmed:authorpubmed-author:KimYong-PilYPlld:pubmed
pubmed-article:12417753pubmed:ownerNLMlld:pubmed
pubmed-article:12417753pubmed:authorsCompleteYlld:pubmed
pubmed-article:12417753pubmed:pagination14728-33lld:pubmed
pubmed-article:12417753pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:12417753pubmed:articleTitleSuppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130.lld:pubmed
pubmed-article:12417753pubmed:affiliationKitasato Institute for Life Sciences and School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417753lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12417753lld:pubmed